| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
27,290,000 |
| Market
Cap: |
59.77(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$2.19 - $2.19 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
19,270,476 |
| Total Buy Value |
$0 |
$0 |
$0 |
$42,395,047 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
2 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Perros Manoussos |
See Remarks |
• • – |
2021-10-19 |
4 |
A |
$0.00 |
$0 |
D/D |
79,750 |
159,500 |
|
- |
|
| Tommasi Ruben |
Chief Scientific Officer |
• – – |
2021-10-19 |
4 |
S |
$3.19 |
$11,991 |
D/D |
(3,759) |
68,265 |
|
46% |
|
| Tommasi Ruben |
Chief Scientific Officer |
• – – |
2021-10-19 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
72,024 |
|
- |
|
| Mueller John Patrick |
Chief Development Officer |
• – – |
2021-10-19 |
4 |
S |
$3.19 |
$12,763 |
D/D |
(4,001) |
45,999 |
|
46% |
|
| Mueller John Patrick |
Chief Development Officer |
• – – |
2021-10-19 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
50,000 |
|
- |
|
| Gutch Michael |
See Remarks |
• – – |
2021-10-19 |
4 |
S |
$3.19 |
$11,991 |
D/D |
(3,759) |
46,241 |
|
46% |
|
| Gutch Michael |
See Remarks |
• – – |
2021-10-19 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
50,000 |
|
- |
|
| Altarac David |
Chief Medical Officer |
• – – |
2021-10-19 |
4 |
S |
$3.19 |
$11,991 |
D/D |
(3,759) |
46,241 |
|
46% |
|
| Altarac David |
Chief Medical Officer |
• – – |
2021-10-19 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
50,000 |
|
- |
|
| Innoviva Strategic Opportunities Llc |
10% Owner |
– – • |
2021-06-11 |
4 |
B |
$2.00 |
$12,537,950 |
I/I |
6,268,975 |
10,000,000 |
1.5 |
21% |
|
| Innoviva Strategic Opportunities Llc |
Director |
– • • |
2021-05-03 |
4 |
B |
$2.00 |
$7,462,050 |
I/I |
3,731,025 |
3,731,025 |
2.25 |
32% |
|
| Hastings David C |
Director |
– • – |
2021-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
22,000 |
22,000 |
|
- |
|
| Behanna Heather |
Director |
– • – |
2021-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
22,000 |
22,000 |
|
- |
|
| Meek David D. |
Director |
– • – |
2021-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
22,000 |
22,000 |
|
- |
|
| Mayer Howard |
Director |
– • – |
2021-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
22,000 |
22,000 |
|
- |
|
| Mueller John Patrick |
Chief Development Officer |
• – – |
2021-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
|
- |
|
| Perros Manoussos |
President & CEO |
• • – |
2021-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
79,750 |
79,750 |
|
- |
|
| Ronsheim Matthew |
See Remarks |
• – – |
2021-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
|
- |
|
| Keiley Elizabeth M |
General Counsel |
• – – |
2021-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
|
- |
|
| Altarac David |
Chief Medical Officer |
• – – |
2021-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
|
- |
|
| Tommasi Ruben |
Chief Scientific Officer |
• – – |
2021-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
47,024 |
|
- |
|
| Gutch Michael |
CFO & CBO |
• – – |
2021-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
|
- |
|
| Theravance Inc |
10% Owner |
– – • |
2020-09-01 |
4 |
B |
$2.68 |
$12,499,999 |
D/D |
4,672,897 |
18,672,897 |
2.45 |
-7% |
|
| Theravance Inc |
10% Owner |
– – • |
2020-06-11 |
4 |
B |
$2.50 |
$31,693,725 |
D/D |
12,677,490 |
14,000,000 |
2.45 |
-32% |
|
| Theravance Inc |
10% Owner |
– – • |
2020-04-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,322,510 |
|
-15% |
|
98 Records found
|
|
Page 3 of 4 |
|
|
